1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Algernon Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease NP-120 (Ifenprodil) - COVID | Phase 2 / Phase 3 | Completed | Algernon Pharmaceuticals | 168 | 2020-08-05 | 2021-12-03 |
ifenprodil (1)
Australia (1) · Philippines (1) · Romania (1) · United States (1)